Published: Apr, 2018

The global diabetic injection pens market is projected to witness a steady rise in the coming years, as reported by Transparency Market Research (TMR). With an overall consolidated vendor landscape, the market presently comprises of a handful of established players, who are predicted to retain their dominance in the forthcoming years. The market players are foretold to focus on implementing the latest technological innovations in order to come up with a unique product portfolio. Leading names in the global diabetes injection pens market include Biocon Ltd., Eli Lilly and Company, Sanofi S.A., and Novo Nordisk A/S.

Between the forecast duration from 2016 to 2024, the global market for diabetes injection pens is expected to exhibit a steady 7.9% CAGR. The market, which was estimated to be US$4.9 bn in the year 2015, is anticipated to reach a valuation of US$9.7 bn by the end of 2024.

diabetes injection pens marketEase of Use to Catapult Insulin Pens Segment to the Fore

Based on product, the segment of insulin pens is expected to show predominance over the pen needles segment over the duration of forecast.  Insulin pens exhibit ease of use as contrasted with syringes and pumps, thereby seeing maximum uptake. The insulin pens segment is projected to grab nearly 64.8% share of the market.

Presently, based on regions, North America holds a substantial market share. This is ascribed to the awareness levels among the population regarding the disease and its control.

Rising Incidence of Diabetes to Push Growth Opportunity for Diabetes Injection Pens Market

According to statistics reported by the American Diabetes Association, in the year 2016, the U.S. alone registered nearly 30.3 million patients were diagnosed with diabetes, making up for almost 9.4% of the total population. Additionally, the BMJ Open Diabetes Research & Care report that roughly 387 million people over the globe are plagued with diabetes, and among them, nearly 5-10 percent suffer from type-1 diabetes.

Additionally, the use of needle-sticks render the patient prone to bacterial infections, and exposes them to the risk of needle stick injuries. This is another factor which could work in favor of the diabetes injection pens market, as the use of this technology is relatively risk free and painless.

Alternative Drug Delivery Modes May Challenge Market Growth

The growing inclination of users towards alternative drug delivery modes could a major hindrance to the market. Moreover, emerging economies are plagued with issues of poor reimbursement schemes offered by the administration. However, the rising prevalence of chronic ailments, support from governments toward improved reimbursement and growing number of regulatory approvals are expected to overcome the market shortcomings and push the growth of the global diabetes injection pens market. 

This review is based    TMR’s report titled, “Diabetes Injection Pens Market (Product - Insulin Pens and Pen Needles; Usage - Reusable Pens and Disposable Pens; Distribution Channels - Hospital Pharmacy, Retail Pharmacy, Online Sales, and Diabetes Clinics/ Centers) - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2016 - 2024.”Top of Form

Key Takeaways:

  • In 2015, North America and Europe accounted for the dominant share in the overall diabetes injection pens market
  • The demand for diabetes injection pens is also expected to be fueled by the increasing cases of needle stick injuries

The market is segmented along the following lines:

Global Diabetes Injection Pens Market, by Product Type

  • Insulin Pens
  • Pen Needles

Global Diabetes Injection Pens Market, by Usage

  • Reusable Pens
  • Disposable Pens

Global Diabetes Injection Pens Market, by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Sales
  • Diabetes Clinics/ Centers

Global Diabetes Injection Pens Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of the Europe
  • Asia
    • China
    • Japan
    • India
    • Indonesia
    • Malaysia
    • Rest of Asia
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Rest of World
    • Australia & New Zealand
    • South Africa
    • RoW

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

U.S. Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com  
Website: https://www.transparencymarketresearch.com 

 

.